Good news
Socialist Organiser1991 1991-08-15Read it in the scan (PDF), scan page 6 →
Read from the scan by machine and not corrected: expect misread words, and now and then a caption or a line from a neighbouring story. For anything you quote, read the scan.
Scan page 6
New genes tor old Dnly 14.2% this year. We'll have to economise. We'll have Trade union leaders, estate agents, and building contractors can take some comfort from the findings of a recent Gallup survey: they all rank above journalists in public esteem.
53 per cent of people questioned by Gallup rated the honesty and ethical standards of journalists as "low" or "very low" • This was considerably worse than the next most despised group, trade union leaders (43 per cent).
The survey went on to ask people how they rated the truthfulness of different sections of the media: BBC television and radio received an overwhelmingly positive response, closely followed by independent television. "Quality" papers like the Times, Guardian and Independent lagged behind the broadcast media, but were generally regarded as "truthful".
The mid-market tabloids (Mail, Express, Today) registered as neutral neither "truthful" nor "untruthful". • But the massmarket tabloids (Sun, Mirror and Star) scored minus-57 per cent.
The answers to other questions told a similar story: the vast majority of people regard the press as politically biased, unwilling to correct mistakes, likely to cover up important stories and much too prone to invade people's privacy.
There is nothing particularly surprising about these LES HEARN'S COLUMN Research into recombitant DNA (inserting "foreign" genetic material into the DNA of organisms) has blossomed over the last 15 years or so. This sounds rather alarming to many people but it is now clear that the process occurs naturally and quite widely throughout the various forms of life.
Whether it is a good or bad thing depends on what gets inserted there. If it's a gene for resistance to a certain type of blight i nto the DNA of Food p lant, this is PRESIS-GANG results: most of us have known (or suspected) all along that despite the anti-TV campaigns of Norman Tebbit, Woodrow Wyatt and Conservative Central Office throughout much of the 1980s, the (regulated) broadcast media is held in much higher general regard than the (free-market) press. Even the most up-market broadsheet papers are less trusted than the TV or radio. But it is the tabloids that really bring the entire British press into disrepute.
Here we encounter one of the great mysteries of our time: surveys like Gallup's must inevitably involve large numbers of tabloid readers; so how is it that millions of people read the tabloids but do not either believe them or approve of them?
The pessimistic explanation would be that most people in this country are hypocrites who operate by a system of dual standards in their choice of newspaper. The optimistic view, that I prefer to believe, is that people buy the tabloids for all sorts of reasons (sports coverage, escapism, enterbeneficial. If it's a gene causing a certain type of cancer (such as is carried by some viruses) then it is pretty bad.
Medical research into recombitant DNA is largely looking at ways of replacing faulty genes or into ways of disabling harmful genes. To illustrate the potential of research, consider cystic fibrosis (CF, a disease in which one gene, active in the cells lining the lungs, is faulty. Healthy copies of the gene would only need to be inserted into the DNA of lung cells, possibly by inhaling an aerosol of disabled viruses, carrying the gene. These viruses would be capable of infecting the cells and inserting the gene into the DNA there but not of multiplying and being released.
But much caution has to be exercised when carrying out such techniques on people. The recombitant genes have to operate in a controlled manner. If they were overactive, or operated in the wrong cells, they could make things worse. Extensive research in animals and in human cells in the test-tube is required to see how the genes would behave.
This was one reason why an unauthorised attempt at gene therapy by a US researcher in the early '80s, was met with condemnation and the loss of his experimental licence. The experiment involved the insertion of a healthy gene for haemoglobin production into cells from the bone marrow of patients with tainment, titillation) but have the good sense not to believe a word they read.
he good news, then, is that even Sun readers maintain a healthy cynicism towards their chosen newspaper. The bad news is that the issue that Gallup respondents felt most strongly about was "invasion of privacy" - and that they did not differentiate signiticantly between "famous people" and "ordinary people" in their disapproval.
This will provide yet more ammunition for the majority of MPs (of all parties) who are just itching to bring in new laws to curb press freedom. The main effect of any such legislation will be to curtail legitimate, "public interest" investigative journalism and the exposure of corruption in high places.
Things are already bad enough on this score: the New Statesman attempted to expose some of BCCI's *irregularities" five years ago, but was silenced by a libel action. As a direct result, the financial journalists of British press were scared off writing anything critical of BCCI until the shit hit the fan last month.
When (not it) legislation is passed, you can blame the the serious blood thalassaemia.
The cells were then transplanted back into the bone marrow, the hope being that healthy red blood cells would be produced.
In the event, the therapy was ineffective but, luckily, neither was it harmful.
Knowledge and techniques have progressed since then, and specific gene therapies have started or are soon to start on a trial basis, after authorisation this time.
One already started, involves putting genes from tumour necrosis factor (INF) into cells from 38 cancer patients. TNF is a protein that specifically attacks tumours, causing their cells to die. Early results are said to be encouraging. One experiment shortly to start would treat victims of inherited hypercholesterolaemia. Sufferers lack a functional gene for making a cell membrane protein that picks up cholesterol from the blood. The result is high levels of cholesterol in the blood and consequent heart disease.
People with one faulty and one normal gene can be treated with drugs, but people with two faulty genes develop life-threatening heart disease as children. Experiments modifying rabbit liver cells have succeeded in substantially lowering the rabbits' blood cholesterol levels.
A different approach to a particular type of leukaemia, is being investigated in cell and, in particular, the Murdoch tabloids. Time and again, they have abused the concept of "press freedom" in order to harass "little people" - the relatives of disaster victims, for example — in order to provide cheap titillation.
The latest victim of this kind of thing looks like being Ms Jill Morrell, the leader of the "Friends of John McCarthy".
Since the release of Mr MeCarthy, the Murdoch press has concentrated its entire coverage on speculation about the state of the personal relationship between Ms Morrell and Mr McCarthy: "Will they, won't they?" was Today's headline on Friday; *I love him as a friend" was the Sun's front page lead on Saturday; *Give 'em a thrill, Jill (England expects a cuddle" urged the News of the World front page.
For five years Ms Morrell and the other "Friends of John McCarthy" had to fight an uphill battle for even a few inches of press coverage. Now that Mr McCarthy is free, the precise nature of a personal relationship between two people who have been through a traumatic experience is front-page news. culture and mouse experiments. The disease, chronic myelogenous leukaemia (CML), responsible for 10% of leukaemia, is caused when an accidental breakage and rearrangement takes place during the DNA copying stage of cell division. This accident joins parts of two genes together to make one abnormal one, and the protein coded for by this new gene, is known to cause the cells that produce white blood cells in the bone marrow to go out of control.
The approach adopted involves putting a short stretch of DNA complementary to part of the abnormal gene into the cells. When the abnormal gene DNA unravels so that its code can be used to make the CML protein, the complementary DNA fragment sticks to it, preventing further progress. The process works in cell culture, but is still a long way from being tried in humans.
If studies in mice are successful, perhaps the technique could be used in patients who are in the acute, lifethreatening stages of the disease. Alternatively, perhaps a gene for the complementary DNA could be made and inserted into bone marrow cells.
Together with several other therapies for cancer and serious genetic illnesses, these experimental techniques represent the first steps what will rapidly becom important new branch medicin-